stoxline Quote Chart Rank Option Currency Glossary
  
American Oncology Network, Inc. (AONC)
9.85  0.55 (5.91%)    11-05 16:00
Open: 9.47
High: 9.85
Volume: 1,120
  
Pre. Close: 9.3
Low: 9.47
Market Cap: 288(M)
Technical analysis
2025-11-05 4:45:33 PM
Short term     
Mid term     
Targets 6-month :  11.5 1-year :  13.43
Resists First :  9.85 Second :  11.5
Pivot price 9.03
Supports First :  9 Second :  8.48
MAs MA(5) :  9.35 MA(20) :  8.96
MA(100) :  10.68 MA(250) :  7.58
MACD MACD :  -0.1 Signal :  -0.2
%K %D K(14,3) :  100 D(3) :  97.2
RSI RSI(14): 61.6
52-week High :  14.25 Low :  3.04
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AONC ] has closed It is unclear right now based on current values. 56.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 9.86 - 9.9 9.9 - 9.94
Low: 9.37 - 9.42 9.42 - 9.46
Close: 9.78 - 9.85 9.85 - 9.92
Company Description

American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.

Headline News

Sat, 29 Mar 2025
American Oncology: A Buy Rating For Bold Growth Investors (OTCMKTS:AONC) - Seeking Alpha

Thu, 27 Mar 2025
American Oncology Network Inc. (AONC) reports earnings - qz.com

Mon, 14 Oct 2024
Glancy Prongay & Murray LLP Announces Investigation of American Oncology Network, Inc. (AONC) (f/k/a Digital Transformation Opportunities Corp.) - Business Wire

Mon, 10 Jun 2024
American Oncology Network Announces the Commencement of OTCQX Trading - Yahoo Finance

Tue, 21 May 2024
American Oncology Network Announces Voluntary Delisting From Nasdaq - Yahoo Finance

Wed, 15 May 2024
American Oncology Network, Inc. Announces First Quarter 2024 Financial Results - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
OTC
Sector:
Healthcare
Industry:
Medical - Care Facilities
Shares Out 13 (M)
Shares Float 4 (M)
Held by Insiders 35.4 (%)
Held by Institutions 0.1 (%)
Shares Short 11 (K)
Shares Short P.Month 23 (K)
Stock Financials
EPS -2.95
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -2.97
Profit Margin 0.1 %
Operating Margin -1.7 %
Return on Assets (ttm) -6.2 %
Return on Equity (ttm) -65.1 %
Qtrly Rev. Growth 37.7 %
Gross Profit (p.s.) 0
Sales Per Share 112.04
EBITDA (p.s.) -2.42
Qtrly Earnings Growth 0 %
Operating Cash Flow -5 (M)
Levered Free Cash Flow 33 (M)
Stock Valuations
PE Ratio -3.36
PEG Ratio 0
Price to Book value -3.33
Price to Sales 0.08
Price to Cash Flow -27.67
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android